Ghelli Luserna Di RorĂ , Andrea
Beeharry, Neil
Imbrogno, Enrica
Ferrari, Anna
Robustelli, Valentina
Righi, Simona
Sabattini, Elena
Verga Falzacappa, Maria Vittoria
Ronchini, Chiara
Testoni, Nicoletta
Baldazzi, Carmen
Papayannidis, Cristina
Abbenante, Maria Chiara
Marconi, Giovanni
Paolini, Stefania
Parisi, Sarah
Sartor, Chiara
Fontana, Maria Chiara
De Matteis, Serena
Iacobucci, Ilaria
Pelicci, Pier Giuseppe
Cavo, Michele
Yen, Timothy J.
Martinelli, Giovanni
Funding for this research was provided by:
National Institutes of Health (CA191956, CA006927)
U.S. Department of Defense (DoD W81XWH-17-1-0136)
Associazione Italiana per la Ricerca sul Cancro (19226)
H2020 European Research Council (306242-NGS-PTL)
Fondazione del Monte di Bologna e Ravenna
Article History
Received: 30 April 2018
Accepted: 12 July 2018
First Online: 1 August 2018
Ethics approval and consent to participate
: The study was approved by the Ethical Committee at Policlinico-Universitario S. Orsola Malpighi. Full informed consent was obtained from all patients.
: Not applicable
: GM has competing interests with Novartis, BMS, Roche, Pfizer, ARIAD, MSD.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.